In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

BackgroundSodium-glucose co-transporter 2 inhibitors (SGLT2-i) have shown significant cardiovascular benefits in patients with and without type 2 diabetes mellitus (T2DM). They have also gained interest for their potential anti-arrhythmic role and their ability to reduce the occurrence of atrial fib...

Full description

Bibliographic Details
Main Authors: Arturo Cesaro, Felice Gragnano, Pasquale Paolisso, Luca Bergamaschi, Emanuele Gallinoro, Celestino Sardu, Niya Mileva, Alberto Foà, Matteo Armillotta, Angelo Sansonetti, Sara Amicone, Andrea Impellizzeri, Giuseppe Esposito, Nuccia Morici, Jacopo Andrea Oreglia, Gianni Casella, Ciro Mauro, Dobrin Vassilev, Nazzareno Galie, Gaetano Santulli, Carmine Pizzi, Emanuele Barbato, Paolo Calabrò, Raffaele Marfella
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
sodium-glucose cotransporter 2 inhibitors (SGLT2-i)
acute myocardial infarction
atrial fibrillation
ventricular arrhythmias
ventricular tachycardia
hyperglycemia
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1012220/full

Similar Items

Similar Items